|
||||||||||||||||||||||||||||||
Green Exchange LLC (GreenX) recently concluded a review of its market data pricing and policies. Effective January 1st 2012, the GreenX new policies and pricing structure will include the implementation of an Annual License Fee and a Monthly User/Device Fee.
The Annual License Fee will be applicable to any customer licensed for GreenX data and redistributing Real Time or Delayed GreenX values. The fee will be $8,400 for the right to redistribute this data.
Additionally, a monthly Per User/Device fee will be implemented for GreenX market data unless all the tenets of the Trading Qualification (Schedule 5.1 of MDLA) are met and approved by an IPM Account Manager. The fee for Real Time data will be $20.00 per month per user/device.
Please see the overview below which outlines a complete list of the new GreenX pricing policies for 2012. If you have any questions, please contact the Information Products Management team at marketdata@cmegroup.com or call us at (312) 634-8395.
|
||||||||||||||||||||||||||||||
As part of a service arrangement with CME Inc., CME Inc. manages market data sales, dissemination and billing for GreenX.
|
About GreenX About CME Group As the world's leading and most diverse derivatives marketplace, CME Group is where the world comes to manage risk. CME Group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. CME Group brings buyers and sellers together through its CME Globex electronic trading platform and its trading facilities in New York and Chicago. CME Group also operates CME Clearing, one of the largest central counterparty clearing services in the world, which provides clearing and settlement services for exchange-traded contracts, as well as for over-the-counter derivatives transactions through CME ClearPort. These products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk in both listed and over-the-counter derivatives markets. |
Manage Subscriptions | Trademarks & Disclaimers | Privacy Policy | CME Group Site Map |